Stephane Esnault1, Elizabeth A Kelly1, Ronald L Sorkness2, Michael D Evans3, William W Busse1, Nizar N Jarjour4. 1. Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis. 2. School of Pharmacy, University of Wisconsin School of Medicine and Public Health, Madison, Wis. 3. Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wis. 4. Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis. Electronic address: nnj@medicine.wisc.edu.
Abstract
BACKGROUND: Coagulation Factor XIII (FXIII) plays an important role in wound healing by stabilizing fibrin clots and cross-linking extracellular matrix proteins. FXIII is expressed in cells of the monocyte/macrophage and dendritic cell lineages in response to type 2 cytokines. OBJECTIVE: We sought to determine the association between FXIII and asthma pathobiology. METHODS: We analyzed the expression of FXIII mRNA and protein levels in bronchoalveolar lavage samples obtained before and after segmental allergen challenge from patients with mild asthma and in induced sputum samples collected from patients with mild-to-moderate and severe asthma. RESULTS: FXIII mRNA and protein levels were highly upregulated in bronchoalveolar cells and fluid after allergen challenge and mRNA levels correlated with protein levels. In sputum of asthmatic patients, FXIII expression was positively correlated with type 2 immune response and dendritic cell markers (CD209 and CD207). FXIII expression was also associated with increased airflow limitation (FEV1/forced vital capacity and residual volume/total lung capacity ratios) and greater reversibility to β-agonists. CONCLUSIONS: FXIII expression was upregulated in the airways of asthmatic patients after allergen exposure. Expression in the sputum of asthmatic patients correlated with the type 2 immune response and airflow limitation. Excessive activity of FXIII could contribute to the pathophysiology of airway obstruction in asthmatic patients.
BACKGROUND: Coagulation Factor XIII (FXIII) plays an important role in wound healing by stabilizing fibrin clots and cross-linking extracellular matrix proteins. FXIII is expressed in cells of the monocyte/macrophage and dendritic cell lineages in response to type 2 cytokines. OBJECTIVE: We sought to determine the association between FXIII and asthma pathobiology. METHODS: We analyzed the expression of FXIII mRNA and protein levels in bronchoalveolar lavage samples obtained before and after segmental allergen challenge from patients with mild asthma and in induced sputum samples collected from patients with mild-to-moderate and severe asthma. RESULTS: FXIII mRNA and protein levels were highly upregulated in bronchoalveolar cells and fluid after allergen challenge and mRNA levels correlated with protein levels. In sputum of asthmatic patients, FXIII expression was positively correlated with type 2 immune response and dendritic cell markers (CD209 and CD207). FXIII expression was also associated with increased airflow limitation (FEV1/forced vital capacity and residual volume/total lung capacity ratios) and greater reversibility to β-agonists. CONCLUSIONS: FXIII expression was upregulated in the airways of asthmatic patients after allergen exposure. Expression in the sputum of asthmatic patients correlated with the type 2 immune response and airflow limitation. Excessive activity of FXIII could contribute to the pathophysiology of airway obstruction in asthmatic patients.
Authors: J Daan de Boer; Christof J Majoor; Cornelis van 't Veer; Elisabeth H D Bel; Tom van der Poll Journal: Blood Date: 2012-01-18 Impact factor: 22.113
Authors: Attila Sárváry; Sándor Szucs; Imre Balogh; Aron Becsky; Helga Bárdos; Mária Kávai; Uri Seligsohn; Rudolf Egbring; Stanislaw Lopaciuk; László Muszbek; Róza Adány Journal: Cell Immunol Date: 2004-04 Impact factor: 4.868
Authors: Cameron T Landers; Hui-Ying Tung; J Morgan Knight; Matthew C Madison; Yifan Wu; Zhimin Zeng; Paul C Porter; Antony Rodriguez; Matthew J Flick; Farrah Kheradmand; David B Corry Journal: J Biol Chem Date: 2019-04-16 Impact factor: 5.157
Authors: Mari T Kaartinen; Mansi Arora; Sini Heinonen; Aila Rissanen; Jaakko Kaprio; Kirsi H Pietiläinen Journal: Int J Mol Sci Date: 2020-11-05 Impact factor: 5.923
Authors: Maria Weitoft; Måns Kadefors; Henning Stenberg; Ellen Tufvesson; Zuzana Diamant; Sara Rolandsson Enes; Leif Bjermer; Oskar Rosmark; Gunilla Westergren-Thorsson Journal: Respir Res Date: 2022-03-05
Authors: Yamini V Virkud; Rachel S Kelly; Damien C Croteau-Chonka; Juan C Celedón; Amber Dahlin; Lydiana Avila; Benjamin A Raby; Scott T Weiss; Jessica A Lasky-Su Journal: Clin Exp Allergy Date: 2018-11-21 Impact factor: 5.018
Authors: Ksenija Bernau; Jonathan P Leet; Heather Floerke; Ellen M Bruhn; Andrea L Noll; Ivy S McDermott; Stephane Esnault; Nizar N Jarjour; Nathan Sandbo Journal: Cells Date: 2021-03-02 Impact factor: 6.600